Search This Blog

Monday, July 29, 2019

Genomic Health EPS beats by $0.07, beats on revenue

Genomic Health (NASDAQ:GHDX): Q2 GAAP EPS of $0.42 beats by $0.07.
Revenue of $114.14M (+19.4% Y/Y) beats by $3.36M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)